Customer Center
Login | Register


Our xTAG® and MultiCode™-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
Read More

Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
Read More

Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
Learn More

Luminex® Blog

Webinar Wednesday: Overcome Biomarker Multiplexing Challenges in Drug Development

Paul Rhyne from BDS Shares Recommended Multiplexing Techniques

Paul Rhyne, PhD, Chief Scientific Officer at Biologic Development Services (BDS), shares insights from a review article co-authored with 11 colleagues from pharmaceutical companies, clinical research organizations (CRO), and government agencies over two years titled: Recommendations for Use and Fit-for-Purpose Validation of Biomarker Multiplex Ligand Binding Assays in Drug Development.

Continue Reading >

xMAP® Technology Overview

Luminex xMAP® Technology Overview


xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.

Watch more videos >

Luminex on Twitter

As you plan your trip to Austin for #Immunology2018, take advantage of our in-person instrument training opportunit…
h J R
RT @Primary_Immune: It's World #PrimaryImmunodeficiency Week 2018 - For Those of Us with One of the ~300 "PI" Disorders...It Matters. #ITRT…
h J R
RT @CDCgov: Outbreak Alert: Throw away ALL store-bought romaine lettuce, including whole heads and hearts, chopped, and salad mixes with r…
h J R

Latest News

March 8
Luminex Corporation to Present at the Barclays Global Healthcare Conference

February 12
Luminex Corporation Reports Fourth Quarter and Full-Year 2017 Financial Results

February 6
Luminex Corporation To Present At LEERINK Partners 7th Annual Global Healthcare Conference

January 24
Luminex Corporation Declares First Quarter Cash Dividend

January 7
Luminex Announces Preliminary Revenue for the Fourth Quarter and Full Year 2017


21-24 April
Madrid, Spain

28 May – 2 June
Malmo, Sweden

PSI Annual Meeting
3-6 June
Beurs Van Berlage, Amsterdam

Drug Discovery Summit
7-8 June
Berlin, Germany

20-23 June
Cologne, Germany